News - Page 63 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders

Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders

Post published:February 16, 2023
Post category:Press Release

Read more about the article First Subject Dosed in Small Pharma’s First-in-Human Phase I Clinical Trial with SPL028

First Subject Dosed in Small Pharma’s First-in-Human Phase I Clinical Trial with SPL028

Post published:February 15, 2023
Post category:Press Release

Read more about the article Israel-Based Clearmind Medicine Strengthening IP Portfolio with Three Provisional Patent Applications in the US

Israel-Based Clearmind Medicine Strengthening IP Portfolio with Three Provisional Patent Applications in the US

Post published:February 15, 2023
Post category:Press Release

Read more about the article Psychedelic Research Bulletin: January 2023

Psychedelic Research Bulletin: January 2023

Post published:February 15, 2023
Post category:Psychedelics Research Review

Read more about the article Delix Therapeutics Partners With Cellectricon, Expressive Neuroscience and Expands Science Team To Accelerate Drug Discovery and Translatability

Delix Therapeutics Partners With Cellectricon, Expressive Neuroscience and Expands Science Team To Accelerate Drug Discovery and Translatability

Post published:February 14, 2023
Post category:Press Release

Read more about the article Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results

Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results

Post published:February 14, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES SECOND PSILOCYBIN SUPPLY AGREEMENT WITH THE CENTRE FOR ADDICTION AND MENTAL HEALTH

FILAMENT HEALTH ANNOUNCES SECOND PSILOCYBIN SUPPLY AGREEMENT WITH THE CENTRE FOR ADDICTION AND MENTAL HEALTH

Post published:February 14, 2023
Post category:Press Release

Read more about the article Israel-Based Clearmind Medicine to Present at The OurCrowd Global Investor Summit Sponsored by Greenberg Traurig Tel Aviv

Israel-Based Clearmind Medicine to Present at The OurCrowd Global Investor Summit Sponsored by Greenberg Traurig Tel Aviv

Post published:February 14, 2023
Post category:Press Release

Read more about the article Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s

Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s

Post published:February 13, 2023
Post category:Press Release

Read more about the article MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

Post published:February 10, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.